J. Berger

Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.

C. Marosi, T. Acker, K. Plate, 2012, Clinical neuropathology.

Expression of Hypoxia-related Tissue Factors Correlates with Diminished Survival of Adjuvantly Treated Patients with Chromosome 1p Aberrant Oligodendroglial Neoplasms and Therapeutic Implications

A. Harris, T. Acker, K. Plate, 2004, Clinical Cancer Research.

The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres

G. Curigliano, M. Berlière, K. Cheung, 2022, European Journal of Cancer.

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

S. Fröhling, B. Brors, D. Beule, 2022, BMC Medicine.

Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas: A clinicopathologic study of 58 patients using mitotic count, MIB‐1 staining, and DNA cytophotometry

W. Jochum, B. Padberg, S. Schröder, 1996, Cancer.

Brief Report: Efficacy of immune checkpoint inhibitors alone or in combination with chemotherapy in NSCLC harboring ERBB2 mutations.

D. Aust, A. Stenzinger, Michael Thomas, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.

A. Hoffmeier, A. Bräuninger, T. Spieker, 2014, Cancer research.

A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.

A. Hoffmeier, A. Bräuninger, T. Dreyer, 2014, Cancer research.